; however, coincubation of endotoxin (100 ng/ml) with platelets and BPAE cells resulted in significantly higher levels of irET. Whether direct contact or adhesion between platelets and endothelial cells is necessary for stimulating irET release was studied by separating platelets from BPAE cells with a 0.4 ,um permeable membrane. Under these conditions, platelets still produced significant elevations (-190% over basal levels) in irET levels in BPAE cell-conditioned medium. In addition, platelet-free buffer from agonist-induced platelet aggregation also significantly enhanced irET production (200%o over basal values). These data indicate that a platelet-derived regulatory factor can induce the biosynthesis of endothelin from cultured endothelial cells and also suggest that platelets might play a role in vasomotor regulation via a novel intercellular interaction with the endothelium. (Circulation Research 1991; 69:832-841) E ndothelin is a very potent vasoactive peptide isolated recently from supernatants of cultured porcine endothelial cells,1 and subsequently, two additional isopeptides have been described to be encoded in the human genome.2 Endothelin (ET-1) was shown originally by Yanagisawa and colleagues1 to be a potent constrictor of the porcine coronary artery in vitro and to produce long-lasting pressor effects in ganglion-blocked rats. Subsequent studies have revealed that receptors for endothelin are present in multiple tissues and organs,3-5 including high-density and high-affinity receptors in cardiac and vascular smooth muscle. [6] [7] [8] These data taken together suggest that endothelin may be involved in modulation of cardiovascular function and blood pressure. The existence of highdensity and high-affinity endothelin receptors in the kidney and the ability of endothelin to produce potent vasoconstriction also raises the possibility that endothelin may be involved in the control of renal function and possibly renal diseases.9-11 In addition, the presence of high-density and high-affinity endothelin receptors in the brain and spinal cord,12-15 as well as endothelin's potent cerebrovascular and autonomic effects,.6 "7 support a role for endothelin in central regulation of the cardiovascular system. However, inasmuch as the cardiovascular and biochemical mechanisms of action of endothelin have been extensively elucidated, little is known about the role endothelin plays in cardiovascular pathophysiology, other than speculation on its ability to produce potent vasoconstriction. In addition, regulatory mechanisms involved in endothelin synthesis are virtually unknown. Recent studies from our laboratory as well as others have demonstrated that trans-forming growth factor-/l (TGF-f1), which is found in large quantities in platelet alpha granules,18 and thrombin (a procoagulant protease formed on platelet surface membranes)19 can induce the expression of endothelin mRNA20 and endothelin biosyntheSiS.20-22 Because platelets can release TGF-l'18 and thrombin formation is localized on the platelet membrane surface,19 it is conceivable that the association of platelets with endothelial cells may be one of the physiological or pathophysiological factors in modulation of endothelin expression or release. Therefore, the aim of the present study was to investigate more directly the interaction between platelets and cultured endothelial cells and to determine the result of this interaction on endothelin biosynthesis. In experiments where the buffer from activated platelets was tested for effects on the production of immunoreactive endothelin (irET) in BPAE cells, washed human platelets (-300,000/,ul) were placed in aggregometer cuvettes and aggregated in an optical aggregometer (Lumi aggregometer, Chrono-Log Corp., Havertown, Pa.) with a platelet agonist as described previously. 23 The aggregation reaction buffer was removed from the cuvette, centrifuged to separate buffer from platelets, and added directly to cultured BPAE cells.
Materials and Methods

Endothelin Radioimmunoassay
Levels of irET in conditioned medium were performed by a radioimmunoassay specific for endothelin (Amersham Corp., Arlington Heights, Ill.) as described previously.21 Briefly, conditioned medium was removed from the culture well, centrifuged at lOOg for 10 minutes, and aliquoted into polypropylene tubes. Rabbit antiserum specific for ET-1 was added to the tubes followed 24 hours later by the addition of '1'I-ET-1. Tubes were incubated for 18 hours at 4°C. Donkey anti-rabbit serum coated onto magnetized polymer particles was incubated in each tube for 10 minutes, and the antibody-bound fraction was separated magnetically. The antiserum for ET-1 had <1% cross-reactivity with endothelin-3 (ET-3) and approximately 35% cross-reactivity with human big endothelin-(1-38) and porcine big endothelin-(1-39). Bovine ET-1 is identical in chemical structure to ET-1.24 irET levels were expressed as femtomoles of irET per 10' cells. The sensitivity of the RIA was 2 fmol/tube, and the 50% intercept was irET production ( Figure 7) . However, the low concen-20986 (WEB, 1 MM), and endotoxin (LPS, 100 ng/ml) ot tration of platelets produced full stimulation of irET platelet-induced stimulation of immunoreactive endothelil production when the platelet activator U46619 (0.1 (irET) in cultured bovinepulmonary artery endothelial cells.i ,uM) or thrombin (0.1 unit/ml) was added to the quantity oflit platelets was added per milliliter of conditione chamber containing the platelets. These data indicate medium. Data are presented as mean +SEM of irET value that platelet-mediated stimulation of irET production from four separate experiments in which each individua does not require direct contact between the endotheexperiment was performed in triplicate or quadruplicate. stimulation of irET production when stimulated further with platelet agonists. Effect ofAgonist-Induced Platelet Degranulation on Production of irET From BPAE cells Additional investigations of the interaction between platelets and endothelial cells involved assessing the effect of cell-free buffer from agonist-induced platelet aggregation on the production of irET from BPAE cells. Washed human platelets were aggregated with thrombin (1 unit/ml) in an optical aggregometer cuvette, and aggregation was monitored. The plateletfree buffer was then added directly to cultured BPAE cells and incubated for 18 hours. Buffer from unstimulated platelets produced a slight, although not statistically significant, stimulation over basal irET levels ( Figure 8 ). However, buffer from thrombin-stimulated platelets had a marked effect on the stimulation of (Figure 9 , top panel). This treatment effectively removed the platelets while the BPAE cells remained attached in the culture plates and were further incubated in new conditioned medium for 17 hours. These experiments demonstrated that irET production was markedly enhanced (-315% over basal levels), even after the removal of platelets. Moreover, when the supernatant from platelets incubated alone for 18 hours was added to BPAE cells, there was a significant increase in irET production (-295% over basal values).
These experiments suggest that a relatively stable, releasable platelet constituent initiates a process for endothelin biosynthesis in endothelial cells and that even after this initial stimulus is removed, the biosynthetic pathway remains stimulated. 
Discussion
The results of this study indicate that platelets can stimulate expression of preproendothelin-1 mRNA and irET production in cultured bovine and human endothelial cells, and priming platelets with aggregatory agonists can enhance the platelet-mediated stimulation of irET production. Moreover, direct adhesion between platelets and endothelial cells may not be required for the platelet-mediated stimulation of endothelin biosynthesis, suggesting that a plateletderived regulatory factor may be responsible for this stimulation.
The ability of low concentrations of thrombin, which do not directly stimulate irET production in endothelial cells, to produce stimulation of irET levels in endothelial cells by subthreshold concentrations of platelets, suggests that thrombin primes platelets to degranulate their alpha granule constituents. Enhanced endothelin biosynthesis by platelets when thrombin is present may reflect synergy between two separate pathways for the stimulation of endothelin biosynthesis: 1) a direct stimulatory pathway by thrombin; and 2) a platelet-dependent pathway. Because TGF-,31 is released during platelet degranulation,18 one can speculate that TGF-,lB is a potential mediator of the platelet-dependent stimulation of irET production, as it has been shown that TGF-pl can directly stimulate endothelin synthesis. [20] [21] [22] In addition, the amount of TGF-f1 released by thrombin-stimulated platelets is approximately equal to the levels required to stimulate endothelin biosynthesis (in the range of 10-1,000 pM). 18 The present data indicate that direct contact between platelets and endothelial cells is not required for stimulation of irET synthesis, because plateletconditioned buffer was capable of stimulating irET The mechanism for platelet-mediated stimulation of endothelin biosynthesis was studied with several different pharmacological tools. Initial studies with platelet activating factor (1 ,gM) showed no significant effect on irET production in cultured BPAE cells (data not shown). However, because of the possibility of rapid transmembrane metabolism,32 definitive conclusions regarding the role of platelet activating factor in the biosynthesis of endothelin is not possible. Therefore, a known platelet activating factor receptor antagonist, WEB 2086,27 was evaluated for platelet-induced endothelin biosynthesis, and no significant effect on endothelin production was observed. Cyclooxygenase products did not appear to effect endothelin production because neither indomethacin nor the thromboxane mimetic U46619 directly influenced irET production.
When endotoxin was added to endothelial cells coincubated with platelets, enhanced stimulation of endothelin biosynthesis was observed. Further support to this concept can be drawn from recent studies33 showing that endotoxin elevated the circulating levels of endothelin in rats in vivo and stimulated the production of endothelin from cultured endothelial cells; however, this latter effect could be shown only when the cells were in the presence of serum, suggesting a role for serum factors in priming endothelial cells for endothelin release by endotoxin. The results of the present study extend this previous report and indicate that blood cells such as platelets might also participate in regulatory mechanisms for endothelial cell endothelin production.
Vanhoutte and colleagues have previously studied functional interactions between platelets and the vascular endothelium. These studies have demonstrated that aggregating platelets produce endothelium-dependent relaxation of blood vessels when the endothelium is intact; however, vasoconstriction is observed when the endothelium is denuded. 34 Figure 10 . Activated platelets release a platelet-derived endothelin regulatory factor (PDERF) that can stimulate the production of endothelin. Endothelin then may produce the release of prostacyclin or endothelium-derived nitric oxide, which will result in inhibition of platelet function and smooth muscle relaxation (for review see Reference 38) Because both thrombin and TGF-f31 are associated with platelet degranulation and aggregation, these studies provide a new perspective for the role of these agents in the modulation of cardiovascular function. Furthermore, the stimulation of preproendothelin-1 mRNA expression and irET levels by a PDERF suggests a novel regulatory pathway for platelet-endothelial cell interaction, and such an interaction might bear significantly on the local regulation of vascular smooth muscle function.
